Supercharging Immunotherapy

fancy black and blue t-cell 3d scientific images immune system

To reprogram the immune system to help overcome cancer and infectious diseases. We do this by using a technology that “supercharges” the natural ability of the immune system to combat disease.

14 Nov 2018

A business professional with more than two decades of executive experience in...

5 Jun 2018

Hookipa and Gilead will jointly develop therapeutics against HIV and Hepatitis...

15 May 2018

TheraT®-induced CD8+ T cells are resistant to select checkpoint inhibitors,...

all news

28 - 30 Nov 2018

San Diego, USA

all events

The source of Hookipa’s strength lies in our people. We value individuals and human rights. We value teamwork. We value diversity - gender, race, nationality, character. We value respect. We want to continue to grow fast as a company and develop as individuals. Get in touch to know more about our career opportunities!

Supercharging Immunotherapy

Our Mission

News

HOOKIPA Appoints Julie O’Neill as a Non-Executive Director

Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop...

New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform...

Our Pipeline

Events

World Vaccine & Immunotherapy Congress West Coast 2018

Careers